Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Cash Flow Quality Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Quality Index of 2.87x as of December 2024. Operating cash flow of CN¥47.07 Million exceeds net income of CN¥16.41 Million, indicating high earnings quality where cash backs reported profits. Explore Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 301258 cash flow metrics.
Annual Cash Flow Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year earnings quality comparison for Suzhou Fushilai Pharmaceutical Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.87x | CN¥47.07 Million | CN¥16.41 Million | ▲ +239.6% |
| 2023 | 0.84x | CN¥94.77 Million | CN¥112.18 Million | ▼ -0.9% |
| 2022 | 0.85x | CN¥151.19 Million | CN¥177.30 Million | ▼ -48.7% |
| 2021 | 1.66x | CN¥199.73 Million | CN¥120.20 Million | ▲ +40.5% |
| 2020 | 1.18x | CN¥166.85 Million | CN¥141.05 Million | ▲ +14.5% |
| 2019 | 1.03x | CN¥150.55 Million | CN¥145.71 Million | — |